|

Incretin-Based Therapy Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Glucagon-like Peptide-1 Receptor Agonist

Phoenix, Arizona1 trial

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.